The selective control of glycolysis, gluconeogenesis and glycogenesis by temporal insulin patterns. 2013

Rei Noguchi, and Hiroyuki Kubota, and Katsuyuki Yugi, and Yu Toyoshima, and Yasunori Komori, and Tomoyoshi Soga, and Shinya Kuroda
Department of Computational Biology, Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Chiba, Japan.

Insulin governs systemic glucose metabolism, including glycolysis, gluconeogenesis and glycogenesis, through temporal change and absolute concentration. However, how insulin-signalling pathway selectively regulates glycolysis, gluconeogenesis and glycogenesis remains to be elucidated. To address this issue, we experimentally measured metabolites in glucose metabolism in response to insulin. Step stimulation of insulin induced transient response of glycolysis and glycogenesis, and sustained response of gluconeogenesis and extracellular glucose concentration (GLC(ex)). Based on the experimental results, we constructed a simple computational model that characterises response of insulin-signalling-dependent glucose metabolism. The model revealed that the network motifs of glycolysis and glycogenesis pathways constitute a feedforward (FF) with substrate depletion and incoherent feedforward loop (iFFL), respectively, enabling glycolysis and glycogenesis responsive to temporal changes of insulin rather than its absolute concentration. In contrast, the network motifs of gluconeogenesis pathway constituted a FF inhibition, enabling gluconeogenesis responsive to absolute concentration of insulin regardless of its temporal patterns. GLC(ex) was regulated by gluconeogenesis and glycolysis. These results demonstrate the selective control mechanism of glucose metabolism by temporal patterns of insulin.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008112 Liver Glycogen Glycogen stored in the liver. (Dorland, 28th ed) Hepatic Glycogen,Glycogen, Hepatic,Glycogen, Liver
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D005943 Gluconeogenesis Biosynthesis of GLUCOSE from nonhexose or non-carbohydrate precursors, such as LACTATE; PYRUVATE; ALANINE; and GLYCEROL.
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006019 Glycolysis A metabolic process that converts GLUCOSE into two molecules of PYRUVIC ACID through a series of enzymatic reactions. Energy generated by this process is conserved in two molecules of ATP. Glycolysis is the universal catabolic pathway for glucose, free glucose, or glucose derived from complex CARBOHYDRATES, such as GLYCOGEN and STARCH. Embden-Meyerhof Pathway,Embden-Meyerhof-Parnas Pathway,Embden Meyerhof Parnas Pathway,Embden Meyerhof Pathway,Embden-Meyerhof Pathways,Pathway, Embden-Meyerhof,Pathway, Embden-Meyerhof-Parnas,Pathways, Embden-Meyerhof
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

Rei Noguchi, and Hiroyuki Kubota, and Katsuyuki Yugi, and Yu Toyoshima, and Yasunori Komori, and Tomoyoshi Soga, and Shinya Kuroda
December 1961, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Rei Noguchi, and Hiroyuki Kubota, and Katsuyuki Yugi, and Yu Toyoshima, and Yasunori Komori, and Tomoyoshi Soga, and Shinya Kuroda
July 1983, Philosophical transactions of the Royal Society of London. Series B, Biological sciences,
Rei Noguchi, and Hiroyuki Kubota, and Katsuyuki Yugi, and Yu Toyoshima, and Yasunori Komori, and Tomoyoshi Soga, and Shinya Kuroda
June 1968, Life sciences,
Rei Noguchi, and Hiroyuki Kubota, and Katsuyuki Yugi, and Yu Toyoshima, and Yasunori Komori, and Tomoyoshi Soga, and Shinya Kuroda
May 1973, The Journal of biological chemistry,
Rei Noguchi, and Hiroyuki Kubota, and Katsuyuki Yugi, and Yu Toyoshima, and Yasunori Komori, and Tomoyoshi Soga, and Shinya Kuroda
November 2016, Science signaling,
Rei Noguchi, and Hiroyuki Kubota, and Katsuyuki Yugi, and Yu Toyoshima, and Yasunori Komori, and Tomoyoshi Soga, and Shinya Kuroda
June 1966, The Biochemical journal,
Rei Noguchi, and Hiroyuki Kubota, and Katsuyuki Yugi, and Yu Toyoshima, and Yasunori Komori, and Tomoyoshi Soga, and Shinya Kuroda
October 1997, Nihon rinsho. Japanese journal of clinical medicine,
Rei Noguchi, and Hiroyuki Kubota, and Katsuyuki Yugi, and Yu Toyoshima, and Yasunori Komori, and Tomoyoshi Soga, and Shinya Kuroda
July 2002, Nihon rinsho. Japanese journal of clinical medicine,
Rei Noguchi, and Hiroyuki Kubota, and Katsuyuki Yugi, and Yu Toyoshima, and Yasunori Komori, and Tomoyoshi Soga, and Shinya Kuroda
March 1969, The Biochemical journal,
Rei Noguchi, and Hiroyuki Kubota, and Katsuyuki Yugi, and Yu Toyoshima, and Yasunori Komori, and Tomoyoshi Soga, and Shinya Kuroda
March 1991, The American journal of physiology,
Copied contents to your clipboard!